Hip Fracture in Cauca. Cohort Study (HIPCCO)

January 15, 2021 updated by: Angela Maria Merchan, Universidad del Cauca

Hip Fracture Cohort in Cauca: Factors That Delay Surgery and Its Outcomes.

This research project is an observational, analytical, prospective cohort study, which aims to identify and describe the causes of delay in surgical intervention in patients with a diagnosis of hip fracture at Hospital Universitario San José, correlate those factors with complications , the impact of the quality of life and the main outcomes in relation to morbidity and mortality associated with the delay in surgery in the study population.

In order to carry out this investigation, the recruitment of patients over 18 years old, who enter our institution with a diagnosis of hip fracture, prior acceptance by the patient or his family member to participate through an informed consent signature is carried out. Subsequently, the research team consults the medical history to monitor the factors that influence the time from admission to surgery. A survey is also conducted to assess the quality of life and how your health status can affect it; which is performed during the hospital stay before surgery, the third day after surgery, one month and 6 months later, the last two surveys are conducted in the control consultation with the treatment team or by call telephone.

It is clear that this study does not represent any risk for the participants, the information collected will be confidential and will not be used for any other purpose outside the investigation.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

Hip fracture is an important cause of disability, functional risk and death in the adult population, being more significant in the elderly, it also entails high costs for the health system. Although it is usually rare before the sixth decade of life and is very rare in young people, patients who present a hip fracture functional risk can be very important, reaching prostration in up to 8% of cases when Your surgical management is delayed. It is known that the time elapsed between diagnosis and treatment that affects the survival of patients, because every two days of surgical waiting doubles the probability of death due to secondary complications such as infections and cardiovascular complications, which impacts on flexibility and quality. of the patient's life. In addition, it should be borne in mind that in occasions it is necessary to stabilize chronic pathologies of the patient, preventing this sea intervened in a timely manner.

At present there is no consensus on the intervention time of these fractures; However, previous studies have found that better results are obtained when surgical treatment is performed within the first 24 hours. In Colombia there are few published studies describing epidemiological characteristics, estimated time from admission to the surgical procedure, and the factors that specific to such delay. Due to the above and considering that hip fracture is considered a public health problem, it is important to identify sociodemographic factors and medical conditions that may be related to the postoperative complications, morbidity and mortality of these patients to help with the taking of therapeutic and administrative decisions that lead to improving the care provided and final results in the patient.

The general objective of this study is to identify the main causes of delay in surgical intervention in patients with a diagnosis of hip fracture of the San José university hospital during 2019 and its relationship with morbidity and mortality.

The research team has also proposed the following specific objectives to carry out this study:

  1. Describe socio-demographically the patients with a diagnosis of hip fracture, underwent surgery at the San José University hospital since 2019.
  2. Identify the reason that delay in surgical intervention.
  3. Quantify the main outcomes in morbidity and mortality during the 6 months after surgery, associated with the delay in surgery in the study population.
  4. Assess the quality of post-surgical life in the patient operated on for hip fracture.
  5. Correlate the delay in surgical intervention with complications and mortality in patients operated for hip fracture since 2019.

It is estimated to include 80 patients during the first year of recruitment. For the collection of information there is a sociodemographic survey, the EQ5D5L quality of life survey and comorbidity is evaluated taking into account the Charlson index.

Study Type

Observational

Enrollment (Anticipated)

150

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Cauca
      • Popayán, Cauca, Colombia, 19001
        • Recruiting
        • Hospital Universitario San José
        • Contact:
        • Contact:
        • Sub-Investigator:
          • Juan P Caicedo, MD
        • Sub-Investigator:
          • Juan M Concha, MD
        • Sub-Investigator:
          • Jose A Calvache, MD, PhD
        • Sub-Investigator:
          • David A Muñoz, MD
        • Sub-Investigator:
          • Felipe Solano, MD
        • Sub-Investigator:
          • Nelson F Sotelo, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

All patients hospitalized at the San José de Popayán University Hospital for surgical correction of hip fractures that meet the inclusion criteria since 2019. Written informed consent will be obtained from all patients.

Description

Inclusion Criteria:

  • Adults (male or female) ≥ 18 years of age
  • Diagnosis of femoral fracture
  • Receiving surgical treatment

Exclusion Criteria:

  • Patients with cognitive disorders that prevent interrogation and assessment of quality of life.
  • Patients referred to another institution for surgery.
  • Patient who decides to voluntarily withdraw from the investigation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Delay surgery
Patients who have passed more than 48 hours from admission to surgery
The specific surgical technique -osteosynthesis, hemiarthroplasty, or total hip arthroplasty- will depend on the characteristics of the proximal femur fracture in each patient.
Other Names:
  • Total hip arthroplasty
  • Hemiarthroplasty

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Delay surgery
Time Frame: 1 month
Time, in hours, from emergency room admission until surgery.
1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
QoL
Time Frame: 12 months

Quality of life whit the 5-level EQ-5D version (EQ-5D-5L generic questionnaire by EuroQol) assessed preoperatively and postoperatively at days 5 and 30 and months 6 and 12.

The EQ-5D-5L measures 5 dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) related to quality of life. Each dimension has 5 levels of severity (no problems, slight problems, moderate problems, severe problems, and extreme problems) which are scored from 1 (no problems) to 5 (extreme problems) points, with the maximum score of 1 indicating a state of full health.

12 months
Mortality
Time Frame: 12 months
All causes mortality
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Angela M Merchán Galvis, MD, MSc, Universidad del Cauca

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 1, 2019

Primary Completion (ACTUAL)

December 31, 2020

Study Completion (ANTICIPATED)

December 31, 2021

Study Registration Dates

First Submitted

January 1, 2020

First Submitted That Met QC Criteria

January 2, 2020

First Posted (ACTUAL)

January 3, 2020

Study Record Updates

Last Update Posted (ACTUAL)

January 20, 2021

Last Update Submitted That Met QC Criteria

January 15, 2021

Last Verified

January 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Fractures

Clinical Trials on Osteosynthesis

Subscribe